Development and License Agreements in Life Sciences
12. November, 8.00–17.00
CHF480Beschreibung/Kontakt
Designing robust agreements and managing risks in long-term collaborations
Organized by LES Switzerland in cooperation with LES Germany.
Program
| 8:30 | Registration |
| 9:00 | Welcome and Introduction Philipp Groz, Dr. Stephanie Pautke |
| 9:15 – 10:15 | Structuring Development and License Deals in Life Sciences Identifying potential collaboration partners: how is this done in practice? Considerations for choosing collaboration type and agreement architecture. Tailoring negotiations: from the term sheet to the long-form agreement. Governance issues. Martin Berchtold, Christoph von Kupsch, Dr. Annette Neikes-Pani |
| 10:15 – 10:45 | Coffee break |
| 10:45 – 11:30 | Upfronts, Milestones and Royalties: Drafting dispute-proof financial clauses Drafting milestone provisions: key concerns from a licensor and licensee perspective and how to address them. Royalty clauses and potential areas of dispute (tiers, caps, floors, royalty stacking, generic entry, net sales definition, audit rights, etc.). Dr. Sevan Antreasyan, Dr. Manja Epping |
| 11:30 – 12:15 | Ownership and Access to IP, Improvements and Data Improvements, data, platform technologies: who owns what, and who may use what for which purpose. Concerns raised by AI use cases. Dr. Markus Albers, Dr. Ute Kilger |
| 12:15 – 12:30 | Q&A |
| 12:30 – 14:00 | Lunch break |
| 14:00 – 14:45 | Termination, Exit Rights and Bankruptcy: Licensor and licensee perspectives Termination triggers (material breach, development failure, safety and regulatory events, change of control, etc.). Post-termination mechanics: data reversion, regulatory issues and transition assistance, fallback licenses. Licensor and licensee bankruptcy and related considerations. Dr. Claudia Milbradt, Dr. Julia Schieber |
| 14:45 – 15:30 | Competition Law Issues in License Collaborations and IP Strategies Recent developments and decisions from a Swiss and EU perspective, including investigations on blocking patents (Novartis), exclusivity and non-compete in pharmaceutical information databases (Vifor) and divisional gaming (Teva/Copaxone), as well as the practical impact of the revised EU Technology Transfer Block Exemption Regulation on licensing contracts in both jurisdictions. Dr. Pranvera Këllezi, Dr. Stephanie Pautke, Prof. Dr. Peter Georg Picht |
| 15:30 – 16:15 | Development and License Agreements: Common areas of disputes Case examples from litigation and arbitration. Practical challenges and learnings from disputes involving monetary aspects (net sales, sublicense revenues, consequences of patent expiration or invalidity) and other topics such as commercially reasonable efforts and scope of license. Dr. Inken Knief, Philipp Groz |
| 16:15 – 16:30 | Q&A / Closing |
| 16:30 – 18:00 | Networking reception |
Speakers
- Dr. Markus Albers – Senior Patent Counsel, Bayer Intellectual Property GmbH, Monheim
- Dr. Sevan Antreasyan – Attorney-at-law, Partner at Lenz & Staehelin, Geneva
- Martin Berchtold, LL.M. – Attorney-at-law, Head Legal Radioligand Therapies, Novartis Pharma AG, Basel
- Dr. Manja Epping – Attorney-at-law, Partner at Heuking, Munich
- Philipp Groz, LL.M. – Attorney-at-law, Partner at Schellenberg Wittmer, Zurich
- Dr. Pranvera Këllezi, LL.M. – Attorney-at-law, Geneva / Member of the Swiss Competition Commission
- Dr. Ute Kilger – German and European Patent Attorney, Partner at Boehmert & Boehmert, Berlin
- Dr. Inken Knief – Attorney-at-law, Partner at Hogan Lovells, Munich
- Christoph von Kupsch, LL.M. – Attorney-at-law, Senior Legal Counsel, Bayer AG, Berlin
- Dr. Claudia Milbradt – Attorney-at-law, Partner at Clifford Chance, Düsseldorf
- Dr. Annette Neikes-Pani – Attorney-at-law, Senior Legal Counsel, Legal Innovation Unit, Boehringer Ingelheim, Ingelheim
- Dr. Stephanie Pautke, LL.M. – Attorney-at-law, Partner at COMMEO, Frankfurt
- Prof. Dr. Peter Georg Picht, LL.M. – Attorney-at-law, University of Zurich / Of Counsel at Schellenberg Wittmer, Zurich
- Dr. Julia Schieber – Attorney-at-law, Partner at Baker McKenzie, Zurich
Venue
Mövenpick Hotel
Aeschengraben 25, 4051 Basel
Registration
- LES member (LES Switzerland or LES Germany): CHF 480
- Young member (up to 40 years of age): CHF 390
- Non-member: CHF 560
Registration includes lunch, coffee breaks and the drinks reception.
Please register by 20 October 2026. Seats are limited, so early registration is recommended. The invoice will be sent by email.